In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...
The U.S. Food and Drug Administration has announced a recall of specific Dexcom (NASDAQ:DXCM) glucose monitoring devices, including the G6, G7, ONE, and ONE+ models. The recall is due to a potential ...
DexCom stock crashed after the company reported disappointing Q2 results and cut its full-year guidance. This performance raised questions about the potential impact of GLP-1 drugs on DexCom's ...
Hosted on MSN
Nearly 640,000 Blood Sugar Devices Have Been Recalled at the Nation’s Highest Risk Level
More than 38 million Americans are estimated to have diabetes—and every year 1.2 million people are diagnosed with the disease, according to the American Diabetes Association. Even for some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results